Italy could have AstraZeneca COVID-19 shots by end November, IRBM biotech says

ROME, Sept 16 (Reuters) - Italy could have its first shots of British drugmaker AstraZeneca's potential COVID-19 vaccine by the end of November, the managing director of IRBM told Reuters.

Biotech firm IRBM, whose lab is based south of Rome, is cooperating with AstraZeneca in developing a vaccine for the disease which has caused more than 35,600 deaths in Italy.

“It is possible to have the first shots in Italy by the end of November, provided the trial continues as planned and the vaccine is validated,” Matteo Liguori said on Wednesday.

Italy’s Health Minister had already said the vaccine could be available by the end of 2020. (Reporting by Emilio Parodi; Writing by Angelo Amante; Editing by Alexander Smith)


Comments - Please in order to comment.

Please peer review 3 community comments before your comment can be posted

A South African Hero: You

There’s a 99.7% chance that this isn’t for you. Only 0.3% of our readers have responded to this call for action.

Those 0.3% of our readers are our hidden heroes, who are fuelling our work and impacting the lives of every South African in doing so. They’re the people who contribute to keep Daily Maverick free for all, including you.

The equation is quite simple: the more members we have, the more reporting and investigations we can do, and the greater the impact on the country.

Be part of that 0.3%. Be a Maverick. Be a Maverick Insider.

Support Daily Maverick→
Payment options

MavericKids vol 3

How can a child learn to read if they don't have a book?

81% of South African children aged 10 can't read for meaning. You can help by pre-ordering a copy of MavericKids.

For every copy sold we will donate a copy to Gift of The Givers for children in need of reading support.